Discovery of epilepsy susceptibility genes: Implications for therapy development and pharmacogenomics

Research output: Contribution to journalReview article

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)731-734
Number of pages4
JournalPharmacogenomics
Volume13
Issue number7
DOIs
StatePublished - May 1 2012

Fingerprint

NAV1.2 Voltage-Gated Sodium Channel
NAV1.1 Voltage-Gated Sodium Channel
Molecular Targeted Therapy
Pharmacogenetics
Genetic Predisposition to Disease
Genetic Therapy
Anticonvulsants
Epilepsy

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

@article{2ec7c2c52bdf4f45b821a1799346fb37,
title = "Discovery of epilepsy susceptibility genes: Implications for therapy development and pharmacogenomics",
author = "Thomas Ferraro",
year = "2012",
month = "5",
day = "1",
doi = "10.2217/pgs.12.31",
language = "English (US)",
volume = "13",
pages = "731--734",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "7",

}

Discovery of epilepsy susceptibility genes : Implications for therapy development and pharmacogenomics. / Ferraro, Thomas.

In: Pharmacogenomics, Vol. 13, No. 7, 01.05.2012, p. 731-734.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Discovery of epilepsy susceptibility genes

T2 - Implications for therapy development and pharmacogenomics

AU - Ferraro, Thomas

PY - 2012/5/1

Y1 - 2012/5/1

UR - http://www.scopus.com/inward/record.url?scp=84861131710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861131710&partnerID=8YFLogxK

U2 - 10.2217/pgs.12.31

DO - 10.2217/pgs.12.31

M3 - Review article

C2 - 22594501

AN - SCOPUS:84861131710

VL - 13

SP - 731

EP - 734

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 7

ER -